ENZYCHEM LIFESCIENCES CORPORATION Q3 operating loss of KRW 4.5 billion on revenue of KRW 20.2 billion
AI summary · Not investment advice
In Q3, the company sold KRW 20.2 billion of goods and lost KRW 4.5 billion from its main business, versus a KRW 3.7 billion loss a year earlier.
Operating profit · 3 months
KRW -4.5 billion
Key facts
- Revenue (3 months)
- KRW 20.2 billion
- Net income (3 months)
- KRW -4.0 billion
- Period
- Q3 (cumulative Jan 1, 2026 ~ Sep 30, 2026)
- Revenue (prior-year 3 months)
- KRW 16.5 billion
- Revenue (year to date)
- KRW 58.6 billion
- Operating profit (prior-year 3 months)
- KRW -3.7 billion
- Operating profit (year to date)
- KRW -11.8 billion
- Net income (prior-year 3 months)
- KRW -3.3 billion
- Net income (year to date)
- KRW -8.7 billion
Commentary
AI commentary · Not investment advice
What happened
Enzychem Lifesciences reported its third-quarter results on a consolidated basis. Sales for the latest 3 months were KRW 20.16 billion. That is 22.4% more than the same period a year earlier and 14.4% less than the previous quarter.
In the company's terms
Operating profit (profit from the core business) for the 3 months was a loss of KRW 4.51 billion. A year earlier, the loss was KRW 3.72 billion. Net income (the final profit after taxes and other items) for the 3 months was a loss of KRW 4.05 billion. A year earlier, the loss was KRW 3.30 billion.
What changes for shareholders
For the cumulative period from January 1 to September 30, sales were KRW 58.60 billion. The operating loss was KRW 11.82 billion. The net loss was KRW 8.71 billion.
Comments
No comments yet
Comments from shareholders will appear here.
Ad
Verify your holdings and catch the next disclosure
Verify the stocks you hold and get new disclosures as app alerts.

App design sample
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist
E